NO166130C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.

Info

Publication number
NO166130C
NO166130C NO872778A NO872778A NO166130C NO 166130 C NO166130 C NO 166130C NO 872778 A NO872778 A NO 872778A NO 872778 A NO872778 A NO 872778A NO 166130 C NO166130 C NO 166130C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
pyridone derivatives
analogy procedure
analogy
Prior art date
Application number
NO872778A
Other languages
English (en)
Norwegian (no)
Other versions
NO872778L (no
NO872778D0 (no
NO166130B (no
Inventor
Fritz Sauter
Ulrich Jordis
Manfred Rudolf
Josef Wieser
Karl Baumann
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of NO872778D0 publication Critical patent/NO872778D0/no
Publication of NO872778L publication Critical patent/NO872778L/no
Publication of NO166130B publication Critical patent/NO166130B/no
Publication of NO166130C publication Critical patent/NO166130C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO872778A 1986-07-04 1987-07-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater. NO166130C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3622509 1986-07-04

Publications (4)

Publication Number Publication Date
NO872778D0 NO872778D0 (no) 1987-07-02
NO872778L NO872778L (no) 1988-01-05
NO166130B NO166130B (no) 1991-02-25
NO166130C true NO166130C (no) 1991-06-05

Family

ID=6304401

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872778A NO166130C (no) 1986-07-04 1987-07-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.

Country Status (24)

Country Link
US (1) US5045549A (fr)
EP (1) EP0251308B1 (fr)
JP (1) JPH07103123B2 (fr)
KR (1) KR880001595A (fr)
AR (1) AR245450A1 (fr)
AT (1) ATE58538T1 (fr)
AU (1) AU608515B2 (fr)
CS (1) CS277415B6 (fr)
DD (1) DD262428A1 (fr)
DE (1) DE3766299D1 (fr)
DK (1) DK342187A (fr)
ES (1) ES2018667B3 (fr)
FI (1) FI88506C (fr)
GR (1) GR3001097T3 (fr)
HU (1) HU197907B (fr)
IL (1) IL83049A (fr)
MY (1) MY101261A (fr)
NO (1) NO166130C (fr)
NZ (1) NZ220950A (fr)
PH (1) PH24239A (fr)
PT (1) PT85257B (fr)
SU (1) SU1551248A3 (fr)
YU (1) YU45039B (fr)
ZA (1) ZA874849B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166416B (fr) * 1985-09-18 1990-05-05 Pfizer
YU46451B (sh) * 1987-04-08 1993-10-20 Chinoin Gyogyszer Es Vegyeszeti Ter Mekek Gyara Rt. Postupak za dobivanje mešovitih anhidrida hinolin-karboksilne i borne kiseline
JPH02131453A (ja) * 1988-04-15 1990-05-21 Asahi Glass Co Ltd ２―クロロ―４，５―ジフルオロベンゾイルアクリル酸誘導体
JPH072679B2 (ja) * 1988-04-15 1995-01-18 旭硝子株式会社 ２―クロロ―４，５―ジフルオロ安息香酸誘導体
WO1989012055A1 (fr) * 1988-06-08 1989-12-14 Kyorin Pharmaceutical Co., Ltd. Agent antitumoral
JPH02298946A (ja) * 1989-05-15 1990-12-11 Johoku Seihan Center:Kk 製版・版下作製材および製版・版下作製における貼付方法
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
AU640481B2 (en) 1990-04-18 1993-08-26 Norwich Eaton Pharmaceuticals, Inc. Penicillan or cephalosporin derivatives of quinolonyl
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
TW252107B (fr) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
ES2092963B1 (es) * 1995-04-12 1997-12-16 Sint Quimica Sa Procedimiento para la preparacion del acido 1-ciclopropil-6-fluoro-1, 4-dihidro-7-(1s,4s)-5-metil-2,5-diazabiciclo(2.2.1) hept-2-il)-4-oxo-3-quinolincarboxilico y sus sales.
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
WO2011031745A1 (fr) 2009-09-09 2011-03-17 Achaogen, Inc. Analogues de fluoroquinolone antibactériens

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292317A (en) * 1977-09-20 1981-09-29 Laboratorie Roger Bellon 1,4-Dihydro-quinoline-3-carboxylic acid derivatives, process for their preparation and compositions containing them
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
EP0058392B1 (fr) * 1981-02-18 1985-11-21 Nippon Shinyaku Company, Limited Dérivés d'acides carboxyliques substitués
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
EP0090424B1 (fr) * 1982-03-31 1986-05-28 Sterling Drug Inc. Dérivés de la quinolone et leur préparation
US4730000A (en) * 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
JPS6056959A (ja) * 1983-07-18 1985-04-02 アボツト　ラボラトリ−ズ キノリン抗菌性化合物
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
EP0181521A1 (fr) * 1984-10-19 1986-05-21 Otsuka Pharmaceutical Co., Ltd. Composés d'acide 1-phényl substitué-4-oxo-3-quinoléine carboxylique
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
IN166416B (fr) * 1985-09-18 1990-05-05 Pfizer
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
US4962108A (en) * 1987-07-31 1990-10-09 Warner-Lambert Company Antibacterial quinoline compounds
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
WO1989005643A1 (fr) * 1987-12-18 1989-06-29 Pfizer Inc. Acides carboxyliques de quinoline a substitution heterocyclique
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents

Also Published As

Publication number Publication date
CS505587A3 (en) 1992-08-12
IL83049A0 (en) 1987-12-31
EP0251308A1 (fr) 1988-01-07
DE3766299D1 (de) 1991-01-03
MY101261A (en) 1991-08-17
EP0251308B1 (fr) 1990-11-22
FI872897A0 (fi) 1987-07-01
PT85257A (en) 1987-08-01
IL83049A (en) 1991-12-12
NO872778L (no) 1988-01-05
SU1551248A3 (ru) 1990-03-15
ZA874849B (en) 1988-03-30
JPS6322580A (ja) 1988-01-30
DK342187A (da) 1988-01-05
ES2018667B3 (es) 1991-05-01
YU45039B (en) 1991-06-30
PT85257B (pt) 1990-03-30
ATE58538T1 (de) 1990-12-15
HU197907B (en) 1989-06-28
CS277415B6 (en) 1993-03-17
NO872778D0 (no) 1987-07-02
FI872897A (fi) 1988-01-05
YU124687A (en) 1988-12-31
DD262428A1 (de) 1988-11-30
KR880001595A (ko) 1988-04-25
FI88506B (fi) 1993-02-15
PH24239A (en) 1990-05-04
NZ220950A (en) 1990-07-26
HUT45060A (en) 1988-05-30
GR3001097T3 (en) 1992-04-17
AR245450A1 (es) 1994-01-31
NO166130B (no) 1991-02-25
US5045549A (en) 1991-09-03
FI88506C (fi) 1993-05-25
DK342187D0 (da) 1987-07-03
AU7508087A (en) 1988-01-07
JPH07103123B2 (ja) 1995-11-08
AU608515B2 (en) 1991-04-11

Similar Documents

Publication Publication Date Title
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
NO162514C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO168103C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater
NO890607D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO168247C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.